FDAnews
www.fdanews.com/articles/150521-novartis-cannibalizes-gleevec-to-boost-new-cancer-drug

Novartis Cannibalizes Gleevec to Boost New Cancer Drug

October 26, 2012
Novartis AG wants patients to stop taking one of its best-selling drugs. The Swiss company revolutionized leukemia treatment with Gleevec, a drug that turned a deadly blood cancer into a chronic disease more than a decade ago.
Businessweek